Gunnebo Interim Report January-June 2014 Comments by

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Jul 16, 2014 at 2:15 AM

Gunnebo Interim Report January-June 2014

Comments by Gunnebo’s President and CEO Per Borgvall “During the second quarter, Group sales increased organically by 6% to MSEK 1,419. Growth was primarily in Region Asia-Pacific (APAC) and Region Americas. In Region Europe, Middle East & Africa (EMEA), sales have continued to stabilise which is satisfactory taking into account developments in recent years. It is also pleasing to see that strategically important product segments for the Group, such as cash handling and entrance security, are continuing to show good growth and margin improvements. Order intake during the quarter decreased by 10% organically on the previous year. In the Americas, a large order was received in Mexico last year with a three-year delivery agreement; no equivalent order was received this year. In APAC, the political elections in India have led the bank sector to pursue a policy of wait and see. The order book is still at a satisfactory level. During the quarter the Group divested the French subsidiary Fichet-Bauche Telesurveillance (FBT), which provides alarm monitoring and call-out services for companies and private customers on the French market. The divestment was part of the ongoing refinement of the Group and it produced capital gains of MSEK 73. Restructuring costs during the period burdened the results by MSEK 30 (12). The costs partly relate to the closure of the production unit in Uckfield, UK, announced in the first quarter, and partly to continued cost adaptations in Europe. Operating profit excluding items of a non-recurring nature increased to MSEK 98 (69) and the operating margin to 6.9% (5.2%). Operating profit increased to MSEK 141 (57) and the operating margin to 9.9% (4.3%). The improvements in profit can primarily be attributed to EMEA where work on cost adaptations has continued to have a positive effect on profit. APAC reported a strong quarter during which the good sales growth contributed to further improvements in the operating margin. The Group’s cash flow during the period was strong as a result of an improved operating profit and the divestment of FBT.” SECOND QUARTER 2014 · Order intake amounted to MSEK 1,330 (1,454), organically a decrease of 10%. · Net sales increased to MSEK 1,419 (1,325), organically they increased by 6%. · Operating profit increased to MSEK 141 (57) and the operating margin to 9.9% (4.3%). · Operating profit excluding items of a non-recurring nature of MSEK 43 (-12) amounted to MSEK 98 (69) and the operating margin to 6.9% (5.2%). · Profit after tax for the period increased to MSEK 106 (34). · Earnings per share were SEK 1.40 (0.45). · Free cash flow*) improved to MSEK 44 (-47). · In June 2014, the French subsidiary Fichet-Bauche Telesurveillance was divested with a capital gain of MSEK 73, which is entered under operating profit as an item of a non-recurring nature. JANUARY-JUNE 2014 · Order intake amounted to MSEK 2,836 (2,953), organically a decrease of 4%. · Net sales increased to MSEK 2,669 (2,480), organically they increased by 7%. · Operating profit increased to MSEK 159 (58) and the operating margin to 6.0% (2.3%). · Operating profit excluding items of a non-recurring nature of MSEK 23 (-22) amounted to MSEK 136 (80) and the operating margin to 5.1% (3.2%). · Profit after tax for the period increased to MSEK 103 (22). · Earnings per share were SEK 1.36 (0.29). · Free cash flow*) improved to MSEK -24 (-99). * Free cash flow is cash flow from operating and investing activities excluding acquisitions and divestments. Full report is attached to this press release. Invitation to Telephone Conference on July 16, 09.00 (CET) To participate in the conference, please sign up using the link below: https://eventreg2.conferencing.com/webportal3...onf=216075 Once registered, you will receive a phone number and a password. 08:55 Call in to the conference 09:00 Review of the interim report by Gunnebo’s President and CEO, Per Borgvall, and CFO, Christian Johansson 09:25 Questions and answers 09:45 Closing of telephone conference Copies of the presentation will be available 30 minutes prior to the telephone conference on www.gunnebogroup.com. Attending from Gunnebo AB are President and CEO, Per Borgvall, and CFO, Christian Johansson. A recording of the telephone conference will be available on www.gunnebogroup.com from late afternoon July 16. GUNNEBO AB (publ) Group Finance For more information, please contact: Per Borgvall, President & CEO Gunnebo AB, tel. +46 10 2095 032, or Christian Johansson, CFO Gunnebo AB, tel. +46 10 2095 032 www.gunnebogroup.com Gunnebo discloses the information provided herein pursuant to the Swedish Securities Markets Act and/or the Financial Instruments Trading Act. The information was submitted for publication at 08.01 CET on July 16, 2014. The Gunnebo Security Group is a global leader in security products, services and solutions with an offering covering cash handling, safes and vaults, entrance security and electronic security for banks, retail, CIT, mass transit, public & commercial buildings and industrial & high-risk sites. The Group has an annual turnover of €610 million, employs 5,600 people and has sales companies in 33 countries across Europe, Middle East & Africa, Asia -Pacific and the Americas as well as Channel Partners on over 100 additional markets. We make your world safer.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's CagriSema Trials Show Promising Weight Loss

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Portillo's Faces Class Action: Investor Losses at Stake

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Championing Change: USTA Mid-Atlantic Gala's Impact

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

JOYEE N01 Debuts Globally with First 2,000 Deliveries

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

WHO and RCSI Bahrain Join Forces on Health Initiatives

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

CVS Study: GLP-1 Drugs Effective But Costly

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Princess Cruises Launches New Era at Celebration Key

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...